SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-012220
Filing Date
2023-04-14
Accepted
2023-04-14 09:05:24
Documents
14
Period of Report
2023-04-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 54473
2 ex99-1.htm EX-99.1 12920
3 ex99-1_001.jpg GRAPHIC 18586
  Complete submission text file 0001493152-23-012220.txt   273130

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE evfm-20230413.xsd EX-101.SCH 3221
5 XBRL LABEL FILE evfm-20230413_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE evfm-20230413_pre.xml EX-101.PRE 22355
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3512
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 23819912
SIC: 2834 Pharmaceutical Preparations